Safety and potential effectiveness of daunorubicin-containing liposomes in patients with advanced recurrent malignant CNS tumors

被引：11

作者：

Boiardi, A

Pozzi, A

Salmaggi, A

Eoli, M

Zucchetti, M

Silvani, A

机构：

[1] Natl Neurol Inst C Besta, Dept Neurol, I-20133 Milan, Italy

[2] Mario Negri Inst, Milan, Italy

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1999年 / 43卷 / 02期

关键词：

D O I：

10.1007/s002800050881

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：178 / 179

页数：2

共 9 条

[1]

ALBRECHT KW, 1997, P ASCO M 17 20 MAY D

[2]

Boiardi A, 1996, J NEURO-ONCOL, V27, P157

[3] AACR SPECIAL CONFERENCE IN CANCER-RESEARCH - MEMBRANE-TRANSPORT IN MULTIDRUG RESISTANCE, DEVELOPMENT, AND DISEASE [J].

DINCALCI, M ;

BROXTERMAN, HJ ;

VANKALKEN, CK .

ANNALS OF ONCOLOGY, 1991, 2 (09) :635-639

[4]

FORSSEN EA, 1992, CANCER RES, V52, P3254

[5]

Forssen Eric A., 1994, Journal of Liposome Research, V4, P481, DOI 10.3109/08982109409037058

[6] Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas [J].

Kaaijk, P ;

Troost, D ;

deBoer, OJ ;

VanAmstel, P ;

Bakker, PJM ;

Leenstra, S ;

Bosch, DA .

BRITISH JOURNAL OF CANCER, 1996, 74 (02) :187-193

[7] CHARACTERIZATION OF AN ESTABLISHED HUMAN, MALIGNANT, GLIOBLASTOMA CELL-LINE (GBM) AND ITS RESPONSE TO CONVENTIONAL DRUGS [J].

PEREGO, P ;

BOIARDI, A ;

CARENINI, N ;

DECESARE, M ;

DOLFINI, E ;

GIARDINI, R ;

MAGNANI, I ;

MARTIGNONE, S ;

SILVANI, A ;

SORANZO, C ;

ZUNINO, F .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1994, 120 (10) :585-592

[8] DOXORUBICIN ENCAPSULATED IN STERICALLY STABILIZED LIPOSOMES FOR THE TREATMENT OF A BRAIN-TUMOR MODEL - BIODISTRIBUTION AND THERAPEUTIC EFFICACY [J].

SIEGAL, T ;

HOROWITZ, A ;

GABIZON, A .

JOURNAL OF NEUROSURGERY, 1995, 83 (06) :1029-1037

[9]

WILES ME, 1997, P ASCO M 17 20 MAY D

← 1 →